NCT00318994View on ClinicalTrials.gov

Evaluation of Pancreatic Tissue Penetration of Meronem® in the Prophylaxis of Septic Complications in Severe Pancreatitis

PHASE4CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

February 28, 2002

Primary Completion Date

September 30, 2005

Study Completion Date

May 31, 2007

Conditions
Pancreatitis
Interventions
DRUG

Meropenem

Trial Locations (1)

Unknown

Research Site, Bogotá

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY